Advertisement
Singapore markets closed
  • Straits Times Index

    3,426.47
    -3.98 (-0.12%)
     
  • Nikkei

    37,667.41
    -202.10 (-0.53%)
     
  • Hang Seng

    17,021.31
    +16.34 (+0.10%)
     
  • FTSE 100

    8,285.71
    +99.36 (+1.21%)
     
  • Bitcoin USD

    68,139.56
    +1,136.30 (+1.70%)
     
  • CMC Crypto 200

    1,380.37
    +49.77 (+3.74%)
     
  • S&P 500

    5,459.10
    +59.88 (+1.11%)
     
  • Dow

    40,589.34
    +654.27 (+1.64%)
     
  • Nasdaq

    17,357.88
    +176.16 (+1.03%)
     
  • Gold

    2,385.70
    +32.20 (+1.37%)
     
  • Crude Oil

    76.44
    -1.84 (-2.35%)
     
  • 10-Yr Bond

    4.2000
    -0.0560 (-1.32%)
     
  • FTSE Bursa Malaysia

    1,612.88
    -2.30 (-0.14%)
     
  • Jakarta Composite Index

    7,288.17
    +47.89 (+0.66%)
     
  • PSE Index

    6,726.01
    +55.74 (+0.84%)
     

Company News for May 10, 2023

  • Shares of Duke Energy Corporation (DUK) declined 0.9% after the company reported first-quarter 2023 earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.29 per share.

  • Lumentum Holdings Inc.’s (LITE) shares fell 4% after the company reported third-quarter fiscal 2023 earnings of $0.75 per share, lagging the Zacks Consensus Estimate of $0.83 per share.

  • Shares of Atkore Inc. (ATKR) gained 0.5% after the company reported second-quarter fiscal 2023 earnings of $4.87 per share, beating the Zacks Consensus Estimate of $4.11 per share.

  • bluebird bio, Inc.’s (BLUE) shares jumped 12.6% after the company reported first-quarter 2023 earnings of $0.21 per share, surpassing the Zacks Consensus Estimate of a loss of $0.54 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Duke Energy Corporation (DUK) : Free Stock Analysis Report

bluebird bio, Inc. (BLUE) : Free Stock Analysis Report

Lumentum Holdings Inc. (LITE) : Free Stock Analysis Report

Atkore Inc. (ATKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research